These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26994242)

  • 41. Malignant hyperthermia genetic testing in North America Working Group Meeting. Bethesda, Maryland. September 4-5, 2002.
    Sei Y; Sambuughin N; Muldoon S
    Anesthesiology; 2004 Feb; 100(2):464-5. PubMed ID: 14870754
    [No Abstract]   [Full Text] [Related]  

  • 42. Identification of a novel mutation in the ryanodine receptor gene (RYR1) in patients with malignant hyperthermia.
    Rueffert H; Kraus H; Olthoff D; Deutrich C; Froster UG
    Hum Mutat; 2001 Mar; 17(3):238. PubMed ID: 11241852
    [No Abstract]   [Full Text] [Related]  

  • 43. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
    Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
    Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Malignant hyperthermia--a hereditary and potentially life-threatening condition].
    Haugen T; Toft M; Müller CR; Aasly J
    Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2792-4. PubMed ID: 16244682
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant Hyperthermia: From the OR to the Sidelines.
    Nelson TE
    Curr Sports Med Rep; 2018 Aug; 17(8):254-255. PubMed ID: 30095544
    [No Abstract]   [Full Text] [Related]  

  • 46. A rare genetic variant of the ryanodine receptor in a suspected malignant hyperthermia susceptible patient.
    MacKay EJ; Wilkerson C; Kraeva N; Rosenberg H; Kennedy T
    J Clin Anesth; 2016 Sep; 33():144-6. PubMed ID: 27555149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A case of discordance between genotype and phenotype in a malignant hyperthermia family.
    Fortunato G; Carsana A; Tinto N; Brancadoro V; Canfora G; Salvatore F
    Eur J Hum Genet; 1999; 7(4):415-20. PubMed ID: 10352931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duchenne muscular dystrophy and malignant hyperthermia: a genetic study of the ryanodine receptor in 47 patients.
    Rohde D; Schmitt HJ; Winterpacht A; Münster T
    Eur J Anaesthesiol; 2014 Jun; 31(6):341-2. PubMed ID: 24557023
    [No Abstract]   [Full Text] [Related]  

  • 49. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.
    Kraeva N; Riazi S; Loke J; Frodis W; Crossan ML; Nolan K; Kraev A; Maclennan DH
    Can J Anaesth; 2011 Jun; 58(6):504-13. PubMed ID: 21455645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Definitive diagnosis of malignant hyperthermia susceptibility by genetic testing: A case report.
    Basile E; McGrath K; Jones K; Apostolov BD; Kahana M
    Paediatr Anaesth; 2023 Oct; 33(10):868-869. PubMed ID: 37357724
    [No Abstract]   [Full Text] [Related]  

  • 51. Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature.
    Nishio H; Sato T; Fukunishi S; Tamura A; Iwata M; Tsuboi K; Suzuki K
    Leg Med (Tokyo); 2009 May; 11(3):142-3. PubMed ID: 19223216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multigenerational Brazilian family with malignant hyperthermia and a novel mutation in the RYR1 gene.
    Matos AR; Sambuughin N; Rumjanek FD; Amoedo ND; Cunha LB; Zapata-Sudo G; Sudo RT
    Braz J Med Biol Res; 2009 Dec; 42(12):1218-24. PubMed ID: 19918671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.
    Brandom BW; Muldoon SM
    Paediatr Anaesth; 2013 Sep; 23(9):851-4. PubMed ID: 23848295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [In vitro contracture test and gene typing in diagnosing malignant hyperthermia. Each as an appropriate complement to the other method].
    Rüffert H; Olthoff D; Deutrich C; Thamm B; Froster U
    Anaesthesist; 2000 Feb; 49(2):113-20. PubMed ID: 10756965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Exciting Couple.
    Etlinger JD
    J Pediatr Ophthalmol Strabismus; 2018 May; 55(3):149-150. PubMed ID: 29796677
    [No Abstract]   [Full Text] [Related]  

  • 56. Response to: The use of guidelines to assess the risk of malignant hyperthermia in individuals with a RYR1 variant.
    Herdewyn S; De Bleecker J; Janssens L; Symoens S; Milazzo M; De Puydt J
    Neuromuscul Disord; 2024 Feb; 35():39. PubMed ID: 38237271
    [No Abstract]   [Full Text] [Related]  

  • 57. In hot pursuit.
    Hogan K
    Anesthesiology; 2006 Dec; 105(6):1077-8. PubMed ID: 17122568
    [No Abstract]   [Full Text] [Related]  

  • 58. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and biochemical characterization of a novel ryanodine receptor gene mutation associated with malignant hyperthermia.
    Anderson AA; Brown RL; Polster B; Pollock N; Stowell KM
    Anesthesiology; 2008 Feb; 108(2):208-15. PubMed ID: 18212565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Out of a cell into this darkened space.
    Parness J; Hogan KJ
    Anesth Analg; 2010 Jul; 111(1):13-6. PubMed ID: 20576962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.